Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Cloughesy

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2007
18F-fluorothymidine kinetics of malignant brain tumorsChristiaan Schiepers, Wei Chen, Magnus Dahlbom, et al.
Cancer Biology & Medicine|January 23, 2015
Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistanceSi-Han Wu, Jun-Feng Bi, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|April 5, 2008
Time course of imaging changes of GBM during extended bevacizumab treatmentSuchitra Ananthnarayan, Jennie Bahng, James Roring, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade gliomaChristiaan Schiepers, Magnus Dahlbom, Wei Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical TrialsRifaquat Rahman, Steffen Ventz, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastomaLorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
International Journal of Molecular Sciences|October 30, 2020
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree BoostingYu Sakai, Chen Yang, Shingo Kihira, et al.
Frontiers in Neuroscience|June 29, 2010
In Silico Enhanced Restriction Enzyme Based Methylation Analysis of the Human Glioblastoma Genome Using Agilent 244K CpG Island MicroarraysAnh Tran, Cameron Escovedo, Justine Migdall-Wilson, et al.
Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade gliomaMirwais Wardak, Christiaan Schiepers, Magnus Dahlbom, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2007
18F-fluorothymidine kinetics of malignant brain tumorsChristiaan Schiepers, Wei Chen, Magnus Dahlbom, et al.
Cancer Biology & Medicine|January 23, 2015
Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistanceSi-Han Wu, Jun-Feng Bi, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|April 5, 2008
Time course of imaging changes of GBM during extended bevacizumab treatmentSuchitra Ananthnarayan, Jennie Bahng, James Roring, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade gliomaChristiaan Schiepers, Magnus Dahlbom, Wei Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical TrialsRifaquat Rahman, Steffen Ventz, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastomaLorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
International Journal of Molecular Sciences|October 30, 2020
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree BoostingYu Sakai, Chen Yang, Shingo Kihira, et al.
Frontiers in Neuroscience|June 29, 2010
In Silico Enhanced Restriction Enzyme Based Methylation Analysis of the Human Glioblastoma Genome Using Agilent 244K CpG Island MicroarraysAnh Tran, Cameron Escovedo, Justine Migdall-Wilson, et al.
Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade gliomaMirwais Wardak, Christiaan Schiepers, Magnus Dahlbom, et al.
Pageof 10